Latest Commercialization News

IDT Australia reports a near doubling of quarterly revenue to $5.3 million, driven by explosive growth in its Advanced Therapies segment, with first-half revenue expected to jump 82%.

Medallion Metals Limited has intersected multiple zones of semi-massive to massive sulphides at its Harbour View deposit, reinforcing confidence in the continuity of mineralisation at the Ravensthorpe Gold Project. Ongoing metallurgical testwork and drilling progress the company toward a Final Investment Decision in late 2025.

West Wits Mining has increased its Mineral Resource Estimate by 749,000 ounces following a new Prospecting Right grant and appointed Rudi Deysel as CEO while advancing project financing for the Qala Shallows Gold Project.

Hawsons Iron Limited is progressing key process optimisation initiatives focused on dry crushing circuits and by-product extraction, while deepening government and investor engagement to enhance the Hawsons Iron Project’s value.

IperionX has completed its inaugural end-to-end titanium powder production cycle using its proprietary HAMR process and secured exclusive rights to breakthrough titanium technologies, positioning itself for expanded manufacturing capacity and strong market demand.

Pureprofile Limited has upgraded its FY25 financial guidance following a robust first half, highlighted by a 22% revenue increase and a 30% surge in Q2, driven by strong international expansion and automation adoption.

CurveBeam AI has broadened its commercial agreement with Stryker to cover Australia and New Zealand, aiming to accelerate adoption of its HiRise weight bearing CT scanners through targeted surgeon education and promotion.

Stellar Resources reports outstanding ore sorting results at its Heemskirk Tin Project, achieving a 2.4-fold increase in tin head grade and up to 95% tin recovery, promising significant cost savings and enhanced production potential.

Sky Metals has intersected significant visual tin mineralisation in the first diamond drill-hole at its Tallebung Tin Project, confirming the deposit remains open in all directions and setting the stage for a major resource expansion.

EMVision Medical Devices reports strong progress in clinical trials for its emu™ Bedside Scanner, backed by robust cash reserves and strategic non-dilutive funding. The company is poised to commence pivotal FDA validation trials, marking a key step toward commercialisation.

De.mem Limited has delivered its second highest quarterly cash receipts ever alongside positive operating cash flow for the December 2024 quarter, marking a milestone full-year cash flow turnaround and setting the stage for continued growth in 2025.

EBR Systems has signed a long-term lease for a 51,000 sq ft facility in Santa Clara, California, positioning itself for significant manufacturing expansion and future growth in wireless cardiac pacing technology.